PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,416,980 | -37.2% | 1,127,782 | 0.0% | 0.05% | -37.9% |
| Q2 2023 | $14,999,501 | +14.9% | 1,127,782 | 0.0% | 0.09% | +22.5% |
| Q1 2023 | $13,059,716 | +41.6% | 1,127,782 | 0.0% | 0.07% | +29.1% |
| Q4 2022 | $9,225,257 | +40.9% | 1,127,782 | 0.0% | 0.06% | +27.9% |
| Q3 2022 | $6,547,000 | -72.8% | 1,127,782 | -79.3% | 0.04% | -68.6% |
| Q2 2022 | $24,067,000 | -51.4% | 5,444,963 | 0.0% | 0.14% | -51.9% |
| Q1 2022 | $49,549,000 | -55.5% | 5,444,963 | 0.0% | 0.28% | -47.4% |
| Q4 2021 | $111,404,000 | -19.9% | 5,444,963 | 0.0% | 0.54% | -11.3% |
| Q3 2021 | $139,119,000 | +24.2% | 5,444,963 | +70.1% | 0.61% | +24.2% |
| Q2 2021 | $111,973,000 | +5.0% | 3,201,972 | 0.0% | 0.49% | +6.5% |
| Q1 2021 | $106,658,000 | +28.4% | 3,201,972 | 0.0% | 0.46% | +47.6% |
| Q4 2020 | $83,059,000 | +158.9% | 3,201,972 | -1.5% | 0.31% | +144.5% |
| Q3 2020 | $32,078,000 | – | 3,250,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WATER ISLAND CAPITAL LLC | 4,718,964 | $24,255,000 | 1.69% |
| HighVista Strategies LLC | 378,479 | $1,945,000 | 1.48% |
| Exane Asset Management | 198,743 | $1,021,539,000 | 1.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,110,666 | $5,709,000 | 1.07% |
| BOURNE LENT ASSET MANAGEMENT INC | 441,650 | $2,270,000 | 1.07% |
| Versor Investments LP | 3,148,691 | $16,184,000 | 0.82% |
| Magnetar Financial LLC | 6,919,655 | $35,567,000 | 0.74% |
| AQR Arbitrage LLC | 6,953,621 | $35,742,000 | 0.60% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 915,124 | $4,704,000 | 0.54% |
| Bellevue Group AG | 5,734,309 | $29,474,000 | 0.47% |